Cyclic AMP-Mediated Inhibition of Cell Growth Requires the Small G Protein Rap1

REFERENCES

• Ahn, N. G.. 1993. The MAP kinase cascade. Discovery of a new signal transduction pathway. Mol. Cell. Biochem. 127–128:201–209.
   PubMedGoogle Scholar
• Alest, L. V., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213–6217.
   PubMedGoogle Scholar
• Altschuler, D., and E. G. Lapetina. 1993. Mutational analysis of the cAMP-dependent protein kinase-mediated phosphorylation site of Rap1b. J. Biol. Chem. 268:7527–7531.
   PubMed Web of Science ®Google Scholar
• Altschuler, D. L., S. N. Peterson, M. C. Ostrowski, and E. G. Lapetina. 1995. Cyclic AMP-dependent activation of Rap1b. J. Biol. Chem. 270:10373–10376.
   PubMedGoogle Scholar
• Altschuler, D. L., and F. Ribeiro-Neto. 1998. Mitogenic and oncogenic properties of the small G protein Rap1b. Proc. Natl. Acad. Sci. USA 95:7475–7479.
   PubMed Web of Science ®Google Scholar
• Anneren, C., K. A. Reedquist, J. L. Bos, and M. Welsh. 2000. GTK, a Src-related tyrosine kinase, induces nerve growth factor-independent neurite outgrowth in PC12 cells through activation of the Rap1 pathway. Relationship to Shb tyrosine phosphorylation and elevated levels of focal adhesion kinase. J. Biol. Chem. 275:29153–29161.
   PubMedGoogle Scholar
• Avruch, J., X.-F. Zhang, and J. M. Kyriakis. 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19:279–283.
   PubMed Web of Science ®Google Scholar
• Blenis, J.. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889–5892.
   PubMed Web of Science ®Google Scholar
• Bos, J. L.. 1998. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17:6776–6782.
   PubMed Web of Science ®Google Scholar
• Burgering, B. M., G. J. Pronk, P. C. van Weeren, P. Chardin, and J. L. Bos. 1993. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12:4211–4220.
   PubMedGoogle Scholar
• Busca, R., P. Abbe, F. Mantoux, E. Aberdam, C. Peyssonnaux, A. Eychene, J. P. Ortonne, and R. Ballotti. 2000. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19:2900–2910.
   PubMed Web of Science ®Google Scholar
• Campa, M. J., K.-J. Chang, L. Molina y Vedia, B. R. Reep, and E. G. Lapetina. 1991. Inhibition of ras-induced germinal vesicle breakdown in Xenopus oocytes by rap-1B. Biochem. Biophys. Res. Commun. 174:1–5.
   PubMed Web of Science ®Google Scholar
• Chen, J., and R. Iyengar. 1994. Suppression of Ras-induced transformation of NIH 3T3 cells by activated Gαs. Science 263:1278–1281.
   PubMedGoogle Scholar
• Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267–5272.
   PubMed Web of Science ®Google Scholar
• Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843–14846.
   PubMed Web of Science ®Google Scholar
• Cobellis, G., C. Missero, and R. Di Lauro. 1998. Concomitant activation of MEK-1 and Rac-1 increases the proliferative potential of thyroid epithelial cells, without affecting their differentiation. Oncogene 17:2047–2057.
   PubMedGoogle Scholar
• Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069–1072.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., B. Rubinfeld, I. Albert, and F. McCormick. 1993. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:3475–3485.
   PubMed Web of Science ®Google Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 77:841–852.
   PubMed Web of Science ®Google Scholar
• Crews, C. M., and R. L. Erikson. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74:215–217.
   PubMed Web of Science ®Google Scholar
• Daaka, Y., L. M. Luttrell, and R. J. Lefkowitz. 1997. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88–91.
   PubMed Web of Science ®Google Scholar
• Day, R. N., J. A. Walder, and R. A. Maurer. 1989. A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J. Biol. Chem. 264:431–436.
   PubMed Web of Science ®Google Scholar
• de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477.
   PubMed Web of Science ®Google Scholar
• de Ruiter, N. D., R. M. Wolthuis, H. van Dam, B. M. Burgering, and J. L. Bos. 2000. Ras-dependent regulation of c-Jun phosphorylation is mediated by the ral guanine nucleotide exchange factor-Ral pathway. Mol. Cell. Biol. 20:8480–8488.
   PubMedGoogle Scholar
• Dhanasekaran, N., L. E. Heasley, and G. L. Johnson. 1995. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocrine Rev. 16:259–270.
   PubMed Web of Science ®Google Scholar
• Downward, J.. 1998. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8:49–54.
   PubMed Web of Science ®Google Scholar
• Downward, J.. 1995. A target for PI(3) kinase. Nature 376:553–554.
   PubMed Web of Science ®Google Scholar
• Dremier, S., F. Vandeput, F. J. Zwartkruis, J. L. Bos, J. E. Dumont, and C. Maenhaut. 2000. Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways. Biochem. Biophys. Res. Commun. 267:7–11.
   PubMed Web of Science ®Google Scholar
• Dugan, L. L., J. S. Kim, Y. Zhang, R. D. Bart, Y. Sun, D. M. Holtzman, and D. H. Gutmann. 1999. Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J. Biol. Chem. 274:25842–25848.
   PubMed Web of Science ®Google Scholar
• Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant Ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235–3243.
   PubMed Web of Science ®Google Scholar
• Franke, B., J.-W. Akkerman, and J. L. Bos. 1997. Rapid Ca2+-mediated activation of rap1 in human platelets. EMBO J. 16:252–259.
   PubMed Web of Science ®Google Scholar
• Franke, B., M. van Triest, K. M. de Bruijn, G. van Willigen, H. K. Nieuwenhuis, C. Negrier, J. W. Akkerman, and J. L. Bos. 2000. Sequential regulation of the small GTPase Rap1 in human platelets. Mol. Cell. Biol. 20:779–785.
   PubMed Web of Science ®Google Scholar
• Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435–437.
   PubMed Web of Science ®Google Scholar
• Gille, H., and J. Downward. 1999. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274:22033–22040.
   PubMed Web of Science ®Google Scholar
• Gong, Q., A. M. Cheng, A. M. Akk, J. Alerola-Ila, G. Gong, T. Pawson, and A. C. Chan. 2000. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat. Immunol. 2:29–36.
   Google Scholar
• Graves, L. M., K. E. Bornfeldt, E. W. Raines, B. C. Potts, S. G. Macdonald, R. Ross, and E. G. Krebs. 1993. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 90:10300–10304.
   PubMed Web of Science ®Google Scholar
• Graves, L. M., H. I. Guy, P. Kozlowski, M. Huang, E. Lazarowski, R. M. Pope, M. A. Collins, E. N. Dahlstrand, H. S. Earp III, and D. R. Evans. 2000. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 403:328–332.
   PubMed Web of Science ®Google Scholar
• Hafner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:6696–6703.
   PubMedGoogle Scholar
• Hata, Y., K. Kaibuchi, S. Kawamura, M. Hiroyoshi, H. Shirataki, and Y. Takai. 1991. Enhancement of the actions of smg p21 GDP/GTP exchange protein by the protein kinase A-catalyzed phosphorylation of smg p21. J. Biol. Chem. 266:6571–6577.
   PubMed Web of Science ®Google Scholar
• Hernandez-Munoz, I., M. Malumbres, P. Leonardi, and A. Pellicer. 2000. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways. Oncogene 19:2745–2757.
   PubMed Web of Science ®Google Scholar
• Herrmann, C., G. Horn, M. Spaargaren, and A. Wittinghofer. 1996. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271:6794–6800.
   PubMed Web of Science ®Google Scholar
• Howe, A. K., and R. L. Juliano. 2000. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat. Cell Biol. 2:593–600.
   PubMed Web of Science ®Google Scholar
• Hu, C. D., K. Kariya, T. Okada, X. Qi, C. Song, and T. Kataoka. 1999. Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J. Biol. Chem. 274:48–51.
   PubMedGoogle Scholar
• Hu, C. D., K. Kariya, G. Kotani, M. Shirouzu, S. Yokoyama, and T. Kataoka. 1997. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1. J. Biol. Chem. 272:11702–11705.
   PubMedGoogle Scholar
• Indolfi, C., E. V. Avvedimento, E. Di Lorenzo, G. Esposito, A. Rapacciuolo, P. Giuliano, D. Grieco, L. Cavuto, A. M. Stingone, I. Ciullo, G. Condorelli, and M. Chiariello. 1997. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat. Med. 3:775–779.
   PubMed Web of Science ®Google Scholar
• Innocente, S. A., J. L. Abrahamson, J. P. Cogswell, and J. M. Lee. 1999. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 96:2147–2152.
   PubMed Web of Science ®Google Scholar
• Joyce, D., B. Bouzahzah, M. Fu, C. Albanese, M. D'Amico, J. Steer, J. U. Klein, R. J. Lee, J. E. Segall, J. K. Westwick, C. J. Der, and R. G. Pestell. 1999. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 274:25245–25249.
   PubMed Web of Science ®Google Scholar
• Kawada, M., S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno, and Y. Uehara. 1997. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629–637.
   PubMed Web of Science ®Google Scholar
• Kawasaki, H., G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D. E. Housman, and A. M. Graybiel. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275–2279.
   PubMed Web of Science ®Google Scholar
• Kerkhoff, E., and U. R. Rapp. 1997. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17:2576–2586.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., M. A. White, J. K. Westwick, P. A. Solski, M. Chrzanowska-Wodnicka, L. Van Aelst, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16:3923–3933.
   PubMed Web of Science ®Google Scholar
• Kikuchi, A., and L. T. Williams. 1996. Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J. Biol. Chem. 271:588–594.
   PubMedGoogle Scholar
• Kim, H. A., J. E. DeClue, and N. Ratner. 1997. cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways. J. Neurosci. Res. 49:236–247.
   PubMed Web of Science ®Google Scholar
• Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A ras-related gene with transformation suppressor activity. Cell 56:77–84.
   PubMed Web of Science ®Google Scholar
• Koch, W. J., B. E. Hawes, L. F. Allen, and R. J. Lefkowitz. 1994. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by Gβγ activation of p21ras. Proc. Natl. Acad. Sci. USA 91:12706–12710.
   PubMedGoogle Scholar
• Koch, W. J., J. Inglese, W. C. Stone, and R. J. Lefkowitz. 1993. The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J. Biol. Chem. 268:8256–8260.
   PubMed Web of Science ®Google Scholar
• Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426–428.
   PubMed Web of Science ®Google Scholar
• Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608–20616.
   PubMed Web of Science ®Google Scholar
• Leevers, S. J., and C. J. Marshall. 1992. MAP kinase regulation—the oncogene connection. Trends Cell Biol. 2:283–286.
   PubMedGoogle Scholar
• Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• Lin, Y., C. Mettling, and C. Chou. 2000. Rap1-suppressed tumorigenesis is concomitant with the interference in ras effector signaling. FEBS Lett. 467:184–188.
   PubMedGoogle Scholar
• Lopez-Llasaca, M., P. Crespo, P. G. Pellicci, J. S. Gutkind, and R. Wetzker. 1997. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science 275:394–397.
   PubMedGoogle Scholar
• MacNicol, M. C., and A. M. MacNicol. 1999. Nerve growth factor-stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase. J. Biol. Chem. 274:13193–13197.
   PubMedGoogle Scholar
• Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. V. Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966–970.
   PubMed Web of Science ®Google Scholar
• McKenzie, F. R., and J. Pouyssegur. 1996. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J. Biol. Chem. 271:13476–13483.
   PubMed Web of Science ®Google Scholar
• Miller, M. J., S. Prigent, E. Kupperman, L. Rioux, S. H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski, and J. L. Meinkoth. 1997. Ra1GDS functions in Ras- and cAMP-mediated growth stimulation. J. Biol. Chem. 272:5600–5605.
   PubMedGoogle Scholar
• Mischak, H., T. Seitz, P. Janosch, M. Eulitz, H. Steen, M. Schellerer, A. Philipp, and W. Kolch. 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16:5409–5418.
   PubMedGoogle Scholar
• Moodie, S. A., B. M. Willumsen, M. J. Weber, and A. Wolfman. 1993. Complexes of ras.GTP with raf-1 and mitogen-activated protein kinase kinase. Science 260:1658–1661.
   PubMed Web of Science ®Google Scholar
• Moore, K. A., R. Sethi, A. M. Doanes, T. M. Johnson, J. B. Pracyk, M. Kirby, K. Irani, P. J. Goldschmidt-Clermont, and T. Finkel. 1997. Rac1 is required for cell proliferation and G2/M progression. Biochem. J. 326:17–20.
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., G. Heidecker, U. R. Rapp, and T. D. Copeland. 1993. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268:17309–17316.
   PubMed Web of Science ®Google Scholar
• Ohtsuka, T., K. Shimizu, B. Yamamori, S. Kuroda, and Y. Takai. 1996. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J. Biol. Chem. 271:1258–1261.
   PubMed Web of Science ®Google Scholar
• Okada, T., C. D. Hu, T. G. Jin, K. Kariya, Y. Yamawaki-Kataoka, and T. Kataoka. 1999. The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases. Mol. Cell. Biol. 19:6057–6064.
   PubMed Web of Science ®Google Scholar
• Olson, M. F., A. Ashworth, and A. Hall. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270–1272.
   PubMed Web of Science ®Google Scholar
• Pagés, G., P. Lenormand, G. L'Allemain, J.-C. Chambard, S. Meloche, and J. Pouysségur. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319–8323.
   PubMed Web of Science ®Google Scholar
• Pastan, I. H., G. S. Johnson, and W. B. Anderson. 1975. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44:491–522.
   PubMed Web of Science ®Google Scholar
• Peraldi, P., M. Frödin, J. V. Barnier, V. Calleja, J.-S. Scimeca, C. Filloux, G. Calothy, and E. Van Obberghen. 1995. Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett. 357:290–296.
   PubMed Web of Science ®Google Scholar
• Peterson, R. T., and S. L. Schreiber. 1999. Kinase phosphorylation: keeping it all in the family. Curr. Biol. 9:R521–R524.
   PubMed Web of Science ®Google Scholar
• Pham, N., I. Cheglakov, C. A. Koch, C. L. de Hoog, M. F. Moran, and D. Rotin. 2000. The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP. Curr. Biol. 10:555–558.
   PubMedGoogle Scholar
• Pizon, V., P. Chardin, and A. Tavitian. 1990. Nucleotide sequence of a human cDNA encoding a ras-related protein (rap 1b). Nucleic Acids Res. 16:7719
   Google Scholar
• Polakis, P. G., B. Rubinfeld, T. Evans, and F. McCormick. 1991. Purification of a plasma membrane-assoicated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells. Proc. Natl. Acad. Sci. USA 88:239–243.
   PubMedGoogle Scholar
• Posern, G., C. K. Weber, U. R. Rapp, and S. M. Feller. 1998. Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts. J. Biol. Chem. 273:24297–24300.
   PubMedGoogle Scholar
• Qiu, R.-G., J. Chen, F. McCormick, and M. Symons. 1995. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781–11785.
   PubMed Web of Science ®Google Scholar
• Qiu, W., S. Zhuang, F. C. von Lintig, G. R. Boss, and R. B. Pilz. 2000. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J. Biol. Chem. 275:31921–31929.
   PubMed Web of Science ®Google Scholar
• Quilliam, L. A., H. Mueller, B. P. Bohl, V. Prossnitz, L. A. Sklar, C. J. Der, and G. M. Bokoch. 1991. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J. Immunol. 147:1628–1635.
   PubMedGoogle Scholar
• Reedquist, K. A., E. Ross, E. A. Koop, R. M. Wolthuis, F. J. Zwartkruis, Y. van Kooyk, M. Salmon, C. D. Buckley, and J. L. Bos. 2000. The Small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148:1151–1158.
   PubMed Web of Science ®Google Scholar
• Rubinfeld, B., S. Munemitsu, R. Clark, L. Conroy, K. Watt, W. J. Crosier, F. McCormick, and P. Polakis. 1991. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell 65:1033–1042.
   PubMed Web of Science ®Google Scholar
• Schmitt, J. M., and P. J. S. Stork. 2000. β2-adrenergic receptor activates extracellular regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf. J. Biol. Chem. 275:25342–25350.
   PubMedGoogle Scholar
• Sevetson, B. R., X. Kong, and J. C. Lawrence Jr.. 1993. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 90:10305–10309.
   PubMed Web of Science ®Google Scholar
• Sidovar, M. F., P. Kozlowski, J. W. Lee, M. A. Collins, Y. He, and L. M. Graves. 2000. Phosphorylation of serine 43 is not required for inhibition of C-Raf kinase by the cAMP-dependent protein kinase. J. Biol. Chem. 275:28688–28694.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., L. A. Feig, and J. B. Gibbs. 1991. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11:4053–4064.
   PubMed Web of Science ®Google Scholar
• Stang, S., D. Bottorff, and J. C. Stone. 1997. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of Rat2 cells. Mol. Cell. Biol. 17:3047–3055.
   PubMed Web of Science ®Google Scholar
• Suhasini, M., H. Li, S. M. Lohmann, G. R. Boss, and R. B. Pilz. 1998. Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway. Mol. Cell. Biol. 18:6983–6994.
   PubMed Web of Science ®Google Scholar
• Takuwa, N., Y. Fukui, and Y. Takuwa. 1999. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70S6K-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 19:1346–1358.
   PubMed Web of Science ®Google Scholar
• Takuwa, N., and Y. Takuwa. 1997. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348–5358.
   PubMed Web of Science ®Google Scholar
• Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621–1627.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
   PubMed Web of Science ®Google Scholar
• Thomas, S. M., M. DeMarco, G. D'Arcangelo, S. Halegoua, and J. S. Brugge. 1992. Ras is essential for nerve growth factor and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68:1031–1040.
   PubMed Web of Science ®Google Scholar
• Treinies, I., H. F. Paterson, S. Hooper, R. Wilson, and C. J. Marshall. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19:321–329.
   PubMedGoogle Scholar
• Tsukamoto, N., M. Hattori, H. Yang, J. L. Bos, and N. Minato. 1999. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J. Biol. Chem. 274:18463–18469.
   PubMed Web of Science ®Google Scholar
• Tsygankova, O. M., E. Kupperman, W. Wen, and J. L. Meinkoth. 2000. Cyclic AMP activates Ras. Oncogene 19:3609–3615.
   PubMed Web of Science ®Google Scholar
• Tsygankova, O. M., A. Saavedra, J. F. Rebhun, L. A. Quilliam, and J. L. Meinkoth. 2001. Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol. Cell. Biol. 21:1921–1929.
   PubMed Web of Science ®Google Scholar
• Vaillancourt, R. R., A. M. Gardner, and G. L. Johnson. 1994. B-Raf dependent regulation of the MEK-1/MAP kinase pathway in PC12 cells and regulation by cAMP. Mol. Cell. Biol. 14:6522–6530.
   PubMedGoogle Scholar
• Vojitek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74:205–214.
   PubMedGoogle Scholar
• von Lintig, F. C., R. B. Pilz, and G. R. Boss. 2000. Quantitative determination of Rap 1 activation in cyclic nucleotide-treated HL-60 leukemic cells: lack of Rap 1 activation in variant cells. Oncogene 19:4029–4034.
   PubMedGoogle Scholar
• Vossler, M., H. Yao, R. York, C. Rim, M.-G. Pan, and P. J. S. Stork. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73–82.
   PubMed Web of Science ®Google Scholar
• Wan, Y., and X. Y. Huang. 1998. Analysis of the Gs/mitogen-activated protein kinase pathway in mutant S49 cells. J. Biol. Chem. 273:14533–14537.
   PubMedGoogle Scholar
• Webb, C. P., L. Van Aelst, M. H. Wigler, and G. F. Woude. 1998. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95:8773–8778.
   PubMedGoogle Scholar
• Wilkinson, M. G., and J. B. Millar. 2000. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J. 14:2147–2157.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Bauer, L. J. van't Veer, A. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. Ra1GDS-like factor (R1f) is a novel Ras and Rap 1A-associating protein. Oncogene 13:353–362.
   PubMedGoogle Scholar
• Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598–5611.
   PubMed Web of Science ®Google Scholar
• Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′, 5′-monophosphate. Science 262:1065–1068.
   PubMed Web of Science ®Google Scholar
• Xing, L., C. Ge, R. Zeltser, G. Maskevitch, B. J. Mayer, and K. Alexandropoulos. 2000. c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase. Mol. Cell. Biol. 20:7363–7377.
   PubMed Web of Science ®Google Scholar
• York, R. D., D. C. Molliver, S. S. Grewal, P. E. Stenberg, E. W. McCleskey, and P. J. Stork. 2000. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol. Cell. Biol. 20:8069–8083.
   PubMed Web of Science ®Google Scholar
• York, R. D., H. Yao, T. Dillon, C. L. Ellig, S. P. Eckert, E. W. McCleskey, and P. J. S. Stork. 1998. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392:622–625.
   PubMed Web of Science ®Google Scholar
• Yoshida, Y., M. Kawata, Y. Miura, T. Musha, T. Sasaki, A. Kikuchi, and U. Takai. 1992. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol. Cell. Biol. 12:3407–3414.
   PubMedGoogle Scholar
• Yung, Y., Y. Dolginov, Z. Yao, H. Rubinfeld, D. Michael, T. Hanoch, E. Roubini, Z. Lando, D. Zharhary, and R. Seger. 1997. Detection of ERK activation by a novel monoclonal antibody. FEBS Lett. 408:292–296.
   PubMedGoogle Scholar
• Zhang, X.-F., J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp, and J. Avruch. 1993. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-raf-1. Nature 364:308–313.
   PubMed Web of Science ®Google Scholar
• Zwartkruis, F. J., and J. L. Bos. 1999. Ras and Rap1: two highly related small GTPases with distinct function. Exp. Cell Res. 253:157–165.
   PubMedGoogle Scholar
• Zwartkruis, F. J., R. M. Wolthuis, N. M. Nabben, B. Franke, and J. L. Bos. 1998. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J. 17:5905–5912.
   PubMed Web of Science ®Google Scholar